Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    Application of economic analysis to diabetes and diabetes care.

    Zhang P, Engelgau MM, Norris SL, Gregg EW, Narayan KM.

    Ann Intern Med. 2004 Jun 1;140(11):972-7. Review.PMID: 15172923 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Economics of diabetes mellitus.

    Krein SL, Funnell MM, Piette JD.

    Nurs Clin North Am. 2006 Dec;41(4):499-511, v-vi. Review.PMID: 17059971 [PubMed - indexed for MEDLINE]Related articles

    3.

    Diabetes mellitus and the St Vincent Declaration. The economic implications.

    Leese B.

    Pharmacoeconomics. 1995 Apr;7(4):292-307. Review.PMID: 10155319 [PubMed - indexed for MEDLINE]Related articles

    4.

    Economic evaluations and diabetes.

    Pathak DS, Burke TA.

    Pharm Pract Manag Q. 1998 Jan;17(4):17-24.PMID: 10174745 [PubMed - indexed for MEDLINE]Related articles

    5.

    Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.

    Griebsch I, Coast J, Brown J.

    Pediatrics. 2005 May;115(5):e600-14. Review.PMID: 15867026 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The cost-effectiveness of intensive therapy for diabetes mellitus.

    Herman WH, Dasbach EJ, Songer TJ, Eastman RC.

    Endocrinol Metab Clin North Am. 1997 Sep;26(3):679-95. Review.PMID: 9314022 [PubMed - indexed for MEDLINE]Related articles

    7.

    When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.

    Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ.

    Crit Care Med. 2006 Nov;34(11):2738-47. Review.PMID: 16957636 [PubMed - indexed for MEDLINE]Related articles

    8.

    The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

    Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

    Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.PMID: 16303098 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.

    Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L, Grant A.

    Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv. Review.PMID: 17083853 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lifetime health effects and costs of diabetes treatment.

    Niessen LW, Dijkstra R, Hutubessy R, Rutten GE, Casparie AF.

    Neth J Med. 2003 Nov;61(11):355-64.PMID: 14768718 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.

    Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Narayan KM, Nwachuku C, O'Connor PJ, Zhang P; ACCORD Study Group.

    Am J Cardiol. 2007 Jun 18;99(12A):90i-102i. Epub 2007 Apr 13.PMID: 17599429 [PubMed - indexed for MEDLINE]Related articles

    14.

    Generalisability in economic evaluation studies in healthcare: a review and case studies.

    Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

    Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.PMID: 15544708 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.

    Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA.

    Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26.PMID: 15324513 [PubMed - indexed for MEDLINE]Related articles

    16.

    The economic analyses of the UK prospective diabetes study.

    Gray AM, Clarke P.

    Diabet Med. 2008 Aug;25 Suppl 2:47-51. Review.PMID: 18717979 [PubMed - indexed for MEDLINE]Related articles

    17.

    Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR).

    Thalanany MM, Mugford M, Hibbert C, Cooper NJ, Truesdale A, Robinson S, Tiruvoipati R, Elbourne DR, Peek GJ, Clemens F, Hardy P, Wilson A; CESAR Trial Group.

    BMC Health Serv Res. 2008 Apr 30;8:94.PMID: 18447931 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

    Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K.

    BMJ. 2008 May 24;336(7654):1180-5. Epub 2008 Apr 21.PMID: 18426840 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions.

    Dalziel K, Segal L.

    Health Promot Int. 2007 Dec;22(4):271-83. Epub 2007 Oct 4. Review.PMID: 17916604 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

    Tappenden P, Jones R, Paisley S, Carroll C.

    Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.PMID: 17346499 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data